Sep 2, 2025, 08:47
SUGAR Trial in Heart BMJ: Stent Outcomes in Patients With Diabetes Under the Spotlight
Heart BMJ posted on X:
”SUGAR and stents: evaluating long-term percutaneous coronary intervention outcomes in patients with diabetes”
Read the full articlle here.
Diabetes makes coronary disease more severe, with narrower, calcified vessels.
Patients with diabetes face higher risks after PCI — heart attack, stent problems, repeat procedures, death.
Risks exist even in silent or pre-diabetes.
Drug-eluting stents improved outcomes but risk stays higher vs. non-diabetics.
The SUGAR trial tested new stents in diabetes — no clear winner yet, but key insights for care.
Stay updated with Haemostasis Today.
-
Jan 27, 2026, 14:06Dmitrii V Kalinin Shares A PhD Opportunity: Hardiman Scholarship
-
Jan 27, 2026, 13:48Filippo Cademartiri: 3 Biomarkers Are Better Than 1: Refining ASCVD Risk in MESA
-
Jan 27, 2026, 12:27Martin Haluzík on Residual Cardiovascular Risk in Coronary Artery Disease
-
Jan 27, 2026, 12:18Stuart Phillips: Strong Bodies Are Good, Informed Bodies Are Better!
-
Jan 27, 2026, 12:07Daniel Torrent: This Should Be An Ice Cold Take… But Veins Aren’t Arteries
-
Jan 27, 2026, 09:17Paolo Zamboni on CCSVI Associated to Multiple Sclerosis
-
Jan 27, 2026, 09:02Rowan Paul: Platelet Dose Determines Success in PRP Therapy
-
Jan 27, 2026, 08:48Uriel Suárez: Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome
-
Jan 27, 2026, 08:23Rossella Crescitelli on Platelets’ and PEVs’ Association with Lung Cancer Metastases